NT69L, a novel analgesic, shows synergy with morphine

M. Boules, A. Shaw, Y. Liang, D. Barbut, E. Richelson

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Background: Neurotensin (NT) is a neuropeptide with antinociceptive effects that are mediated through NT receptors, of which there are three known subtypes (NTS1, NTS2, and NTS3). Morphine is a μ-opioid receptor agonist commonly used for pain treatment but is associated with side effects that can be serious. We hypothesize that selective NT receptor agonists may represent a novel class of analgesics and their use in conjunction with morphine will have synergistic properties which may reduce the dose of morphine administered and its side effects. Methods: The antinociceptive activity of an NT agonist (NT69L) and morphine was studied in rats using the hot plate test to determine if there is synergism between the two drugs in reducing pain. The NTS2 receptor antagonist, levocabastine, was used to determine the receptor subtype involved in the analgesic effect of NT69L and morphine. Results: The administration of both NT69L and morphine resulted in a dose-dependent analgesic effect. The isobolographic analysis demonstrated that the combination of sub-analgesic doses of NT69L and morphine was synergistic in the hot plate test. Pretreatment with the NTS2 receptor antagonist, levocabastine attenuated the antinociceptive effect of NT69L and the combined effect of NT69L and morphine in the hot plate test. Conclusion: The results support the hypothesis that the synergistic combination of NT69L and morphine would improve the pharmacological treatment of pain while minimizing specific adverse effects of each of the drugs at a higher dose. NTS2 is important for the antinociceptive effect of NT69L and morphine.

Original languageEnglish (US)
Pages (from-to)22-28
Number of pages7
JournalBrain Research
Volume1294
DOIs
StatePublished - Oct 6 2009

Fingerprint

Morphine
Analgesics
levocabastine
Neurotensin Receptors
Neurotensin
Pain
neurotensin 69L
Opioid Receptors
Neuropeptides
Pharmaceutical Preparations
Pharmacology
Therapeutics

Keywords

  • Antinociception
  • Hot plate
  • Morphine
  • Neurotensin
  • Rat
  • Synergism

ASJC Scopus subject areas

  • Neuroscience(all)
  • Clinical Neurology
  • Developmental Biology
  • Molecular Biology

Cite this

Boules, M., Shaw, A., Liang, Y., Barbut, D., & Richelson, E. (2009). NT69L, a novel analgesic, shows synergy with morphine. Brain Research, 1294, 22-28. https://doi.org/10.1016/j.brainres.2009.07.086

NT69L, a novel analgesic, shows synergy with morphine. / Boules, M.; Shaw, A.; Liang, Y.; Barbut, D.; Richelson, E.

In: Brain Research, Vol. 1294, 06.10.2009, p. 22-28.

Research output: Contribution to journalArticle

Boules, M, Shaw, A, Liang, Y, Barbut, D & Richelson, E 2009, 'NT69L, a novel analgesic, shows synergy with morphine', Brain Research, vol. 1294, pp. 22-28. https://doi.org/10.1016/j.brainres.2009.07.086
Boules M, Shaw A, Liang Y, Barbut D, Richelson E. NT69L, a novel analgesic, shows synergy with morphine. Brain Research. 2009 Oct 6;1294:22-28. https://doi.org/10.1016/j.brainres.2009.07.086
Boules, M. ; Shaw, A. ; Liang, Y. ; Barbut, D. ; Richelson, E. / NT69L, a novel analgesic, shows synergy with morphine. In: Brain Research. 2009 ; Vol. 1294. pp. 22-28.
@article{66e3c1e1cafb4e799518e50242f4fc2a,
title = "NT69L, a novel analgesic, shows synergy with morphine",
abstract = "Background: Neurotensin (NT) is a neuropeptide with antinociceptive effects that are mediated through NT receptors, of which there are three known subtypes (NTS1, NTS2, and NTS3). Morphine is a μ-opioid receptor agonist commonly used for pain treatment but is associated with side effects that can be serious. We hypothesize that selective NT receptor agonists may represent a novel class of analgesics and their use in conjunction with morphine will have synergistic properties which may reduce the dose of morphine administered and its side effects. Methods: The antinociceptive activity of an NT agonist (NT69L) and morphine was studied in rats using the hot plate test to determine if there is synergism between the two drugs in reducing pain. The NTS2 receptor antagonist, levocabastine, was used to determine the receptor subtype involved in the analgesic effect of NT69L and morphine. Results: The administration of both NT69L and morphine resulted in a dose-dependent analgesic effect. The isobolographic analysis demonstrated that the combination of sub-analgesic doses of NT69L and morphine was synergistic in the hot plate test. Pretreatment with the NTS2 receptor antagonist, levocabastine attenuated the antinociceptive effect of NT69L and the combined effect of NT69L and morphine in the hot plate test. Conclusion: The results support the hypothesis that the synergistic combination of NT69L and morphine would improve the pharmacological treatment of pain while minimizing specific adverse effects of each of the drugs at a higher dose. NTS2 is important for the antinociceptive effect of NT69L and morphine.",
keywords = "Antinociception, Hot plate, Morphine, Neurotensin, Rat, Synergism",
author = "M. Boules and A. Shaw and Y. Liang and D. Barbut and E. Richelson",
year = "2009",
month = "10",
day = "6",
doi = "10.1016/j.brainres.2009.07.086",
language = "English (US)",
volume = "1294",
pages = "22--28",
journal = "Brain Research",
issn = "0006-8993",
publisher = "Elsevier",

}

TY - JOUR

T1 - NT69L, a novel analgesic, shows synergy with morphine

AU - Boules, M.

AU - Shaw, A.

AU - Liang, Y.

AU - Barbut, D.

AU - Richelson, E.

PY - 2009/10/6

Y1 - 2009/10/6

N2 - Background: Neurotensin (NT) is a neuropeptide with antinociceptive effects that are mediated through NT receptors, of which there are three known subtypes (NTS1, NTS2, and NTS3). Morphine is a μ-opioid receptor agonist commonly used for pain treatment but is associated with side effects that can be serious. We hypothesize that selective NT receptor agonists may represent a novel class of analgesics and their use in conjunction with morphine will have synergistic properties which may reduce the dose of morphine administered and its side effects. Methods: The antinociceptive activity of an NT agonist (NT69L) and morphine was studied in rats using the hot plate test to determine if there is synergism between the two drugs in reducing pain. The NTS2 receptor antagonist, levocabastine, was used to determine the receptor subtype involved in the analgesic effect of NT69L and morphine. Results: The administration of both NT69L and morphine resulted in a dose-dependent analgesic effect. The isobolographic analysis demonstrated that the combination of sub-analgesic doses of NT69L and morphine was synergistic in the hot plate test. Pretreatment with the NTS2 receptor antagonist, levocabastine attenuated the antinociceptive effect of NT69L and the combined effect of NT69L and morphine in the hot plate test. Conclusion: The results support the hypothesis that the synergistic combination of NT69L and morphine would improve the pharmacological treatment of pain while minimizing specific adverse effects of each of the drugs at a higher dose. NTS2 is important for the antinociceptive effect of NT69L and morphine.

AB - Background: Neurotensin (NT) is a neuropeptide with antinociceptive effects that are mediated through NT receptors, of which there are three known subtypes (NTS1, NTS2, and NTS3). Morphine is a μ-opioid receptor agonist commonly used for pain treatment but is associated with side effects that can be serious. We hypothesize that selective NT receptor agonists may represent a novel class of analgesics and their use in conjunction with morphine will have synergistic properties which may reduce the dose of morphine administered and its side effects. Methods: The antinociceptive activity of an NT agonist (NT69L) and morphine was studied in rats using the hot plate test to determine if there is synergism between the two drugs in reducing pain. The NTS2 receptor antagonist, levocabastine, was used to determine the receptor subtype involved in the analgesic effect of NT69L and morphine. Results: The administration of both NT69L and morphine resulted in a dose-dependent analgesic effect. The isobolographic analysis demonstrated that the combination of sub-analgesic doses of NT69L and morphine was synergistic in the hot plate test. Pretreatment with the NTS2 receptor antagonist, levocabastine attenuated the antinociceptive effect of NT69L and the combined effect of NT69L and morphine in the hot plate test. Conclusion: The results support the hypothesis that the synergistic combination of NT69L and morphine would improve the pharmacological treatment of pain while minimizing specific adverse effects of each of the drugs at a higher dose. NTS2 is important for the antinociceptive effect of NT69L and morphine.

KW - Antinociception

KW - Hot plate

KW - Morphine

KW - Neurotensin

KW - Rat

KW - Synergism

UR - http://www.scopus.com/inward/record.url?scp=70049106921&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70049106921&partnerID=8YFLogxK

U2 - 10.1016/j.brainres.2009.07.086

DO - 10.1016/j.brainres.2009.07.086

M3 - Article

C2 - 19651107

AN - SCOPUS:70049106921

VL - 1294

SP - 22

EP - 28

JO - Brain Research

JF - Brain Research

SN - 0006-8993

ER -